INCB054828pharmacokinetics and pharmacodynamics were investigated using cell lines andtumor models, and the antitumor effect of oral INCB054828 was investigated usingxenograft tumor models with genetic alterations in FGFR1, 2, or 3. This evidence concerns the gene FGFR1 and neoplasm.